Close Window

Digital Look Email A Friend

Poolbeg inks exclusive deal for melioidosis vaccine candidate

Published by Josh White on 21st September 2022

(Sharecast News) - Clinical-stage infectious disease pharmaceutical company Poolbeg Pharma has signed an exclusive licence agreement with University College Dublin (UCD), it announced on Wednesday, for a late preclinical-stage vaccine candidate for melioidosis.

URL: http://www.digitallook.com/dl/news/story/32978932/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.